Ardena buys Spain’s Idifarma in move to capitalize on emerging biotech segment 06-Sep-2021 By Jane Byrne Ardena has acquired Idifarma, a contract manufacturer of niche and highly potent generic and innovative drugs, from Suanfarma; the deal enables it to expand across Southern Europe and supports its strategy to become a leading global CDMO.